Lincoln Pharmaceuticals Ltd Performance
Day's Low
Day's High
₹765Day's Price Range₹807.652 Week's Low
52 Week's High
₹534.852-Week Price Range₹979.5
| Returns % | |
| 1 Month Return | -0.54 % |
| 3 Month Return | + 20.76 % |
| 1 Year Return | + 20.54 % |
| Market Stats | |
| Previous Close | ₹798.00 |
| Open | ₹800.05 |
| Volume | 44.20K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,598.37Cr |
Lincoln Pharmaceuticals Ltd Key Statistics
| P/E Ratio | 16.54 |
| PEG Ratio | 2.1 |
| Market Cap | ₹1,598.37 Cr |
| P/B Ratio | 1.98 |
| EPS | 46.58 |
| Dividend Yield | 0.31 |
| Sector | Pharmaceuticals |
| ROE | 17.04 |
Lincoln Pharmaceuticals Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹1,598.37 Cr | 59.11% | 0.50 | ₹93 Cr | ₹580 Cr | |
| NA | ₹271.68 Cr | 110.1% | 0.52 | ₹16 Cr | ₹108 Cr | |
| NA | ₹2,152.42 Cr | 5.69% | 0.52 | NA | NA | |
| NA | ₹142.69 Cr | 3.78% | 0.59 | NA | NA | |
| NA | ₹93.75 Cr | 10.89% | 0.54 | NA | NA |
About Lincoln Pharmaceuticals Ltd
Share Price: ₹770.20 per share as on 21 Jan, 2025 04:01 PM
Market Capitalisation: ₹1,598.37Cr as of today
Revenue: ₹161.21Cr as on September 2024 (Q3 24)
Net Profit: ₹26.33Cr as on September 2024 (Q3 24)
Listing date: 17 Dec, 2015
Chairperson Name: Kishorbhai M Shah
| Organisation | Lincoln Pharmaceuticals Ltd |
| Headquarters | Ahmedabad |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Key events for Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Stock Surges 7.88% on January 1, 2025 - 01 Jan, 2025
On January 1, 2025, Lincoln Pharmaceuticals stock rose by 7.88%, outperforming its sector. The stock reached an intraday high of Rs 857.6 and showed a monthly increase of 35.78%. Despite high volatility, it remains above key moving averages, with a Hold rating from MarketsMOJO.Lincoln Pharmaceuticals Surges 7.83% on December 30 - 30 Dec, 2024
On December 30, 2024, Lincoln Pharmaceuticals gained 7.83%, outperforming its sector. The stock reached an intraday high of Rs 794.95 and has risen 32.86% over the past month, while the Sensex declined by 1.46%. It is rated as Hold by MarketsMOJO, indicating a stable outlook.Lincoln Pharmaceuticals Hits Upper Circuit with Strong Performance - 03 Dec, 2024
On December 3, 2024, Lincoln Pharmaceuticals' stock surged 20% to Rs 763.20, driven by high trading volumes and increased FII stake. The company reported consistent profit growth and aims for Rs 750 crore revenue by FY26, bolstered by strong liquidity and zero debt.
Insights on Lincoln Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 months, LINCOLN stock has moved up by 14.2%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 18.6 Cr → 26.33 Cr (in ₹), with an average increase of 15.8% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, LINCOLN has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 45.03% to 45.06% in Dec 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 149.51 Cr → 171.19 Cr (in ₹), with an average increase of 6.5% per quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 49.78% of holdings in Dec 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 33.5%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 5.19% to 5.16% in Dec 2024 quarter
Lincoln Pharmaceuticals Ltd Financials
Index Inclusions
Lincoln Pharmaceuticals Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 49.78% | 0.00 | |
| Foreign Institutions | 5.16% | ||
| Mutual Funds | 0% | 38.46 | |
| Retail Investors | 45.06% | 0.07 | |
| Others | 0% |
Lincoln Pharmaceuticals Ltd Key Indicators
Lincoln Pharmaceuticals Ltd Valuation
Lincoln Pharmaceuticals Ltd in the last 5 years
Lowest (3.58x)
March 23, 2020
Today (16.54x)
January 20, 2025
Industry (55.28x)
January 20, 2025
Highest (19.77x)
December 9, 2024
Lincoln Pharmaceuticals Ltd Earnings and Dividends
Lincoln Pharmaceuticals Ltd Earnings Results
Lincoln Pharmaceuticals Ltd’s net profit fell -4.77% since last year same period to ₹26.33Cr in the Q2 2024-2025. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated 11.24% jump in its net profits since last 3-months.
Read More about Earnings ResultsLincoln Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, Lincoln Pharmaceuticals Ltd has declared dividend of ₹1.80 - translating a dividend yield of 0.43%.
Read More about Dividends
Lincoln Pharmaceuticals Ltd Technicals Summary
Bearish
Neutral
Bullish
Lincoln Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Lincoln Pharmaceuticals Ltd
Lincoln Pharmaceuticals Ltd share price today stands at ₹770.2, Open. ₹800.05 ; Previous Close. ₹798 ; High. ₹807.6 ; Low. ₹765 ; 52 Week High. ₹979.5 ; 52 Week Low: ₹534.8.
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Lincoln Pharmaceuticals Ltd shares.
Lincoln Pharmaceuticals Ltd is listed on NSE
Lincoln Pharmaceuticals Ltd is listed on BSE
- Today’s highest price of Lincoln Pharmaceuticals Ltd is ₹807.6.
- Today’s lowest price of Lincoln Pharmaceuticals Ltd is ₹765.
PE Ratio of Lincoln Pharmaceuticals Ltd is 16.54
PE ratio = Lincoln Pharmaceuticals Ltd Market price per share / Lincoln Pharmaceuticals Ltd Earnings per share
Today’s traded volume of Lincoln Pharmaceuticals Ltd(LINCOLN) is 44.20K.
Today’s market capitalisation of Lincoln Pharmaceuticals Ltd(LINCOLN) is ₹1598.37Cr.
| Lincoln Pharmaceuticals Ltd(LINCOLN | Price |
|---|---|
52 Week High | ₹979.5 |
52 Week Low | ₹534.8 |
Lincoln Pharmaceuticals Ltd(LINCOLN) share price is ₹770.2. It is down -21.37% from its 52 Week High price of ₹979.5
Lincoln Pharmaceuticals Ltd(LINCOLN) share price is ₹770.2. It is up 44.02% from its 52 Week Low price of ₹534.8
| Lincoln Pharmaceuticals Ltd(LINCOLN | Returns |
|---|---|
1 Day Returns | -27.8% |
1 Month Returns | -0.54% |
3 Month Returns | 20.76% |
1 Year Returns | 20.54% |